http://www.vioxxadvisor.com Get the ultimate advice for Vioxx users! Thu, 21 Aug 2008 15:01:03 +0000 http://backend.userland.com/rss092 Partial payments for people claiming withdrawn painkiller Vioxx caused heart attacks will go out starting Aug. 28 under the $4.85 billion settlement between drugmaker Merck & Co. and plaintiffs' lawyers, the claims administrator said today. Click here for more info http://www.vioxxadvisor.com/4481.html Partial payments for people claiming withdrawn painkiller Vioxx caused heart attacks will go out starting Aug. 28 under the $4.85 billion settlement between drug maker Merck and plaintiffs' lawyers, the claims administrator said Wednesday. Read more here http://www.vioxxadvisor.com/4480.html TRENTON - Partial payments for people claiming the withdrawn painkiller Vioxx caused heart attacks will go out starting Aug. 28 under the $4.85 billion settlement between drug maker Merck & Co. and plaintiffs' lawyers, the claims administrator said Wednesday. Click here for more info http://www.vioxxadvisor.com/4479.html Partial payments for people claiming the painkiller Vioxx caused heart attacks will go out starting Aug. 28 under the $4.85 billion settlement between drugmaker Merck and plaintiffs' lawyers, the claims administrator said yesterday. Click here for more info http://www.vioxxadvisor.com/4478.html Partial payments for people claiming withdrawn painkiller Vioxx caused heart attacks will go out starting Aug. 28 under the $4.85 billion settlement between drugmaker Merck & Co. and plaintiffs' lawyers, the claims administrator said today. Read more here http://www.vioxxadvisor.com/4477.html Starting Aug. 28, the Whitehouse Station, N.J.-based drugmaker will send the first round of checks to claimants who charged its drug Vioxx caused heart attacks and strokes. Nearly 50,000 claims have been filed. Read more here http://www.vioxxadvisor.com/4476.html TRENTON - Partial payments for people claiming that withdrawn painkiller Vioxx caused heart attacks will go out starting Aug. 28 under the $4.85 billion settlement between drugmaker Merck & Co. and plaintiffs' lawyers, the claims administrator said today. Click here for more info http://www.vioxxadvisor.com/4475.html Partial payments for people claiming withdrawn painkiller Vioxx caused heart attacks will go out starting Aug. 28 under the $4.85 billion settlement between drugmaker Merck & Co. and plaintiffs' lawyers, the claims administrator said Wednesday. Read more here http://www.vioxxadvisor.com/4474.html TRENTON, N.J. — A 1999 Merck & Co. study of its since-withdrawn painkiller Vioxx, touted to participating doctors and patients as meant to show whether Vioxx caused fewer stomach problems than another drug, was primarily a stealth marketing strategy, researchers report. Read more here http://www.vioxxadvisor.com/4473.html The latest twist in Merck's ongoing troubles from its since-withdrawn painkiller Vioxx took another painful turn Monday for the drugmaker. Click ... http://www.vioxxadvisor.com/4472.html Report cites Merck memos on painkiller Merck & Co.'s marketing department devised a study on the painkiller Vioxx to persuade 600 doctors involved in the trial to prescribe the drug and recommend it to their peers, researchers said. ... http://www.vioxxadvisor.com/4471.html Merck & Co.'s marketing department devised a study on the painkiller Vioxx to convince 600 doctors involved in the trial to prescribe the drug and recommend it to their peers, researchers say. Link to original article http://www.vioxxadvisor.com/4470.html TRENTON, N.J. – A 1999 Merck Co. study of its since-withdrawn painkiller Vioxx, touted to participating doctors and patients as showing that Vioxx caused fewer stomach problems than another drug, was primarily a stealth marketing strategy, researchers report. More... http://www.vioxxadvisor.com/4469.html Trenton, N.J. - A 1999 Merck & Co. study of its since-withdrawn painkiller Vioxx, touted to participating doctors and patients as a way to show whether Vioxx caused fewer stomach problems than another drug, was primarily a stealth marketing strategy, More... http://www.vioxxadvisor.com/4468.html Merck & Co.'s marketing department devised a study on the painkiller Vioxx to persuade 600 doctors involved in the trial to prescribe the drug and recommend it to their peers, researchers say. Read more here http://www.vioxxadvisor.com/4465.html A 1999 Merck & Co. study of its since-withdrawn painkiller Vioxx was primarily a stealth marketing strategy, researchers report. Link to original article http://www.vioxxadvisor.com/4466.html TRENTON, N.J. . A 1999 Merck . Co. study of its since-withdrawn painkiller Vioxx . touted to participating doctors and patients as meant to show whether Vioxx caused fewer stomach problems than another drug . was primarily a stealth marketing strategy, researchers report. The true purpose ... http://www.vioxxadvisor.com/4467.html A 1999 clinical study that Merck & Co Inc said was done to test side effects of painkiller Vioxx was conducted primarily to support a marketing campaign before the drug's launch, The Wall Street Journal said, citing a study. More... http://www.vioxxadvisor.com/4461.html Aug. 19 (Bloomberg) -- A Merck & Co. study of Vioxx that the company said showed whether the painkiller was easier on the stomach than an older drug was actually a marketing tool to boost sales, according to researchers. Read more here http://www.vioxxadvisor.com/4462.html A 1999 Merck study of its since-withdrawn painkiller Vioxx, presented to participating doctors and patients as a trial designed to show whether Vioxx caused fewer stomach problems than another drug, was primarily a stealth marketing strategy, researchers report. More... http://www.vioxxadvisor.com/4463.html TRENTON, N.J. (AP) -- A 1999 Merck & Co. study of its since-withdrawn painkiller Vioxx, meant to show whether Vioxx caused fewer stomach problems than another drug, was primarily a stealth marketing strategy, researchers report. Link to original article http://www.vioxxadvisor.com/4464.html For the third time in three years, a prominent medical journal has criticized Merck & Co. for misrepresenting research on its now-withdrawn painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4460.html A 1999 Merck & Co. study of its since-withdrawn painkiller Vioxx, touted to participating doctors and patients as meant to show whether Vioxx caused fewer stomach problems than another drug, was primarily a stealth marketing strategy, researchers report. Click here for more info http://www.vioxxadvisor.com/4459.html Our weekly wrap-up of our online "Ask the Experts" questions looks at tax answers from IRS expert Kathy Howell and estate issues from trust attorney Trudy Nearn. Trudy Nearn The founder of Generations law firm is an expert on wills, trusts and estate ... http://www.vioxxadvisor.com/4458.html Two painkillers pulled from the market in recent years -- Vioxx (also known as rofecoxib) and Bextra (also known as valdecoxib) - increase the risk of stroke, new research indicates. More... http://www.vioxxadvisor.com/4457.html Americans are likely to be exposed to unacceptable side effects of FDA-approved drugs such as Vioxx in the future because of fatal flaws in the way new drugs are tested and marketed, according to research to be presented at the annual meeting of the American Sociological Association (ASA). More... http://www.vioxxadvisor.com/4456.html BOSTON — Americans are likely to be exposed to unacceptable side effects of FDA-approved drugs such as Vioxx in the future because of fatal flaws in the way new drugs are tested and marketed, according to research to be presented today at the annual meeting of the American Sociological Association ... http://www.vioxxadvisor.com/4455.html Justice Maurice Cullity of the Ontario Superior Court of Justice ordered that an action relating to the prescription drug VIOXX be certified as a national class action excluding residents of Quebec and Saskatchewan. Link to original article http://www.vioxxadvisor.com/4454.html A Canadian court has certified another class-action lawsuit against Merck & Co. over its former painkiller Vioxx, for which the U.S. drug maker is doling out billions of dollars to cover American settlements. Link to original article http://www.vioxxadvisor.com/4453.html Plaintiffs attorneys say a recent surge in lawsuits involving two recalled drugs, generic blood thinner heparin and prescription medication Digitek, could signal a clean break from past actions that were far less successful against Vioxx and Paxil. Click here for more info http://www.vioxxadvisor.com/4452.html Merck , the US pharmaceuticals group, played down the risks of taking its painkiller Vioxx in reports in academic journals and early submissions to regulators, according to a study to be published on Wednesday. More... http://www.vioxxadvisor.com/4451.html People who suffered heart attacks while taking Vioxx could receive a partial settlement check as early as next month. Merck & Co., the maker of Vioxx, said more than 97 percent of nearly 50,000 claimants agreed to terms of the $4.85 billion settlement announced last fall. Read more here http://www.vioxxadvisor.com/4450.html Alabama Attorney Jere Beasley Helped Bring Settlement for People who Took Vioxx Click here for more info http://www.vioxxadvisor.com/4449.html Merck & Co. will start cutting checks for former users of its withdrawn painkiller Vioxx next month after announcing it will fund a $4.9 billion settlement expected to resolve 50,000 lawsuits. Link to original article http://www.vioxxadvisor.com/4447.html TRENTON, N.J. -- Merck & Co.'s $4.85 billion fund to settle legal claims over the withdrawn painkiller Vioxx will begin making payments next month to former users or surviving family members who say the drug caused heart attacks or strokes. Merck will contribute its first installment of $500 million into ... http://www.vioxxadvisor.com/4448.html Merck will begin making payouts next month to consumers who agreed to settle lawsuits over injuries they claim were caused by using the pain-relief drug Vioxx. Read more here http://www.vioxxadvisor.com/4446.html Merck will start cutting checks for former users of its withdrawn painkiller Vioxx next month after announcing Thursday it will fund a $4.85 billion settlement expected to resolve roughly 50,000 lawsuits. ... http://www.vioxxadvisor.com/4445.html TRENTON, N.J. (AP) _ Merck & Co. will start cutting checks for former users of its withdrawn painkiller Vioxx next month after announcing Thursday that it will fund a $4.85 billion settlement expected to resolve roughly 50,000 lawsuits. ... http://www.vioxxadvisor.com/4444.html TRENTON, N.J. - Drugmaker Merck & Co. will start cutting checks for former users of its withdrawn painkiller Vioxx next month, after announcing Thursday that it will fund a $4.85 billion settlement expected to resolve roughly 50,000 lawsuits alleging harm from Vioxx. Click here for more info http://www.vioxxadvisor.com/4443.html Merck & Co. will start cutting checks for former users of its withdrawn painkiller Vioxx next month after announcing Thursday that it will fund a $4.85 billion settlement expected to resolve roughly 50,000 lawsuits. Read more here http://www.vioxxadvisor.com/4442.html Merck says it will fund the $4.85 billion settlement designed to resolve tens of thousands of lawsuits related to its Vioxx painkiller, waiving its right to walk away from the settlement deal. Read more here http://www.vioxxadvisor.com/4441.html Merck & Co said on Thursday that more than 97 percent of eligible U.S. claimants had elected to participate in its $4.85 billion proposed Vioxx settlement, an adequate number to trigger funding of the program. Link to original article http://www.vioxxadvisor.com/4440.html Associated Press - July 17, 2008 8:34 AM ET WHITEHOUSE STATION, N.J. (AP) - Merck says it will fund the $4.85 billion settlement designed to resolve tens of thousands of lawsuits related to its Read more here http://www.vioxxadvisor.com/4439.html Merck & Co. has dropped Lowenstein Sandler from its appeal of a $13.5 million Vioxx case to prevent recusal of a potentially pro-company New Jersey Supreme Court justice who the firm represents in a private matter. Lowenstein partner Douglas Eakeley won't argue for Merck at the state high court because ... http://www.vioxxadvisor.com/4438.html Nearly four years after Merck & Co. yanked the painkiller Vioxx off the market, beleaguered pharmaceutical industry executives say they are facing a tough new regulatory climate that is altering the landscape of drug development. Click here for more info http://www.vioxxadvisor.com/4437.html Nearly four years after Merck & Co. yanked the painkiller Vioxx off the market, beleaguered pharmaceutical-industry executives say they are facing a tough new regulatory climate that is altering the landscape of drug development. Over the past 16 months, Schering-Plough Corp. Chief Executive Fred Hassan and his top scientists have ... http://www.vioxxadvisor.com/4436.html More than 59,000 people have registered claims against drugmaker Merck & Co. for injury from painkiller Vioxx, and administrators have enough records to review about 9,100 of those claims. Read more here http://www.vioxxadvisor.com/4435.html More than 59,000 people have registered claims against Readington-based drugmaker Merck & Co. for injury from painkiller Vioxx, and administrators have enough records to review about 9,100 of those claims. More... http://www.vioxxadvisor.com/4433.html VIOXX CLAIMS: More than 59,000 people have registered claims in the $4.85-billion settlement against drugmaker Merck & Co. for injuries from its painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4434.html Lawyers say more than 59,000 people have registered for drugmaker Merck & Co.'s settlement of lawsuits claiming injury from the painkiller Vioxx. Administrators have enough records to review about 9,100 of those claims. Read more here http://www.vioxxadvisor.com/4431.html NEW ORLEANS -- More than 59,000 people hope to share in drugmaker Merck and Co.'s settlement of lawsuits claiming injury from the painkiller Vioxx, and administrators have enough Click here for more info http://www.vioxxadvisor.com/4432.html Malcolm MacMeikan, a kitchen and refrigeration consultant, first realised something was wrong when he had a panic attack during a building site visit at Canary Wharf. More... http://www.vioxxadvisor.com/4430.html Malcolm MacMeikan, a kitchen and refrigeration consultant, first realised something was wrong when he had a panic attack during a building site visit at Canary Wharf. Click here for more info http://www.vioxxadvisor.com/4429.html Biz Buzz: Is it hot in here, or is it just a climate-law blog? Lawyers are prodigious bloggers, posting on the progress of Vioxx litigation, shareholder suits and the vagaries of divorce law. So it was only a matter of time before they got to global warming. Link to original ... http://www.vioxxadvisor.com/4428.html The New Jersey Supreme Court ruled that Vioxx users who suffered no known personal injury could not sue the company to pay for electrocardiograms and follow-up consultations with cardiologists. Click here for more info http://www.vioxxadvisor.com/4427.html Appeals courts in two US states last week overturned verdicts favouring plaintiffs who had sued Merck, the pharmaceutical giant, over its painkiller Vioxx (rofecoxib). The drug was taken off the market in 2004 after a study showed it doubled the risk of heart attacks and strokes. Link to original article ... http://www.vioxxadvisor.com/4426.html TRENTON, N.J., June 4 (UPI) -- The New Jersey Supreme Court ruled Wednesday Merck is not obligated to pay for the medical monitoring of people who took Vioxx. More... http://www.vioxxadvisor.com/4424.html The New Jersey Supreme Court ruled that Vioxx users who suffered no known harm from the withdrawn pain drug cannot sue Merck & Co Inc to pay for medical tests and treatment by heart doctors, the drugmaker said on Wednesday. Link to original article http://www.vioxxadvisor.com/4425.html The New Jersey Supreme Court ruled that Vioxx users who suffered no known harm from the withdrawn pain drug cannot sue Merck & Co Inc to pay for medical tests and treatment by heart doctors, the drugmaker said on Wednesday. Link to original article http://www.vioxxadvisor.com/4422.html Drugmaker Merck & Co. is not liable for the medical monitoring of Vioxx users not claiming injury, the New Jersey Supreme Court ruled Wednesday. The 5-1 ruling by the state's highest court means a class-action lawsuit by people who used the once-popular ... http://www.vioxxadvisor.com/4420.html The New Jersey Supreme Court ruled Wednesday that Merck is not liable for the medical monitoring of Vioxx users not claiming injury. Link to original article http://www.vioxxadvisor.com/4421.html A ruling by the New Jersey Supreme Court dismisses a class-action lawsuit by people who used Vioxx. Read more here http://www.vioxxadvisor.com/4423.html http://www.vioxxadvisor.com/4415.html NEWARK, N.J. (AP) -- The New Jersey Supreme Courts has ruled that Merck is not liable for the medical monitoring of Vioxx users not claiming injury. The 5-1 ruling means a class-action lawsuit by people who used the once-popular painkiller will be dismissed. One justice did not participate. More... http://www.vioxxadvisor.com/4416.html NEWARK — The New Jersey Supreme Courts rules Merck is not liable for the medical monitoring of Vioxx users not claiming injury. The 5-1 ruling means a class-action lawsuit by people who used the once-popular painkiller will be dismissed. One justice did not participate. The court says the users are ... http://www.vioxxadvisor.com/4417.html The New Jersey Supreme Courts rules Merck is not liable for the medical monitoring of Vioxx users not claiming injury. The 5-1 ruling means a class-action lawsuit by people who used the once-popular painkiller will be dismissed. One justice did not participate. Click here for more info http://www.vioxxadvisor.com/4418.html The New Jersey Supreme Court ruled Readington-based Merck & Co. is not liable for the medical monitoring of Vioxx users not claiming injury. More... http://www.vioxxadvisor.com/4419.html Mark Lanier, the 47-year-old attorney who litigated his way to CNBC fame by taking on Merck’s dreaded Vioxx, and who’s now representing sugar-cane farmers in their suit against Splenda, is doubling the size of his footprint in Harry Macklowe ’s Tower 56 . ... http://www.vioxxadvisor.com/4414.html State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system -- at least at the appellate level," according to a Wall Street Journal editorial. More... ... http://www.vioxxadvisor.com/4413.html Merck & Co., Inc. said that it is gratified that a Texas appeals court overturned the August 2005 verdict of a state court jury in Brazoria County and rendered a judgment in favour of Merck in the Vioxx product liability case Ernst v. Merck. Click here for more info http://www.vioxxadvisor.com/4412.html SAN FRANCISCO (Thomson Financial) - Merck & Co.'s Merck Frosst Canada Ltd. late Friday said it planned to appeal a ruling by a Canadian court expanding the scope of the previously certified class-action lawsuit over its recalled painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4411.html SAN FRANCISCO (Thomson Financial) - Merck & Co.'s Merck Frosst Canada Ltd. late Friday said it planned to appeal a ruling by a Canadian court expanding the scope of the previously certified class-action lawsuit over its recalled painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4410.html State appeals courts in New Jersey and Texas on Thursday reversed two jury verdicts and a judgment on payment of legal fees in lawsuits related to the COX-2 inhibitor Vioxx that would have required Merck to pay about $37 million, Bloomberg/Washington Post reports (Van Voris/Voreacos, Bloomberg/Washington Post, 5/30). Link to ... http://www.vioxxadvisor.com/4409.html NEWARK, N.J. - Appeals courts in New Jersey and Texas yesterday scrapped verdicts against drugmaker Merck & Co. Inc. stemming from some of the earliest trials involving the company's now withdrawn pain reliever Vioxx. More... http://www.vioxxadvisor.com/4408.html Merck's persistence may be paying off. Appeals courts in Texas and New Jersey handed the drugmaker a series of victories in three Vioxx lawsuits yesterday, overturning an entire verdict in Texas and reversing key components of two New Jersey cases. Link to original article http://www.vioxxadvisor.com/4404.html The major victories for Merck pushed the litigation over Vioxx closer to conclusion and highlighted the difficulty that plaintiffs’ lawyers are having in winning lawsuits against big drug companies. Link to original article http://www.vioxxadvisor.com/4405.html A Houston appellate court Thursday overturned a $26 million Angleton jury finding that a 59-year-old triathlete died because of his use of the popular painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4406.html NEWARK — Appeals courts in New Jersey and Texas on Thursday scrapped verdicts against the drug maker Merck & Co. Inc. stemming from some of the earliest trials involving its once popular painkiller Vioxx. More... http://www.vioxxadvisor.com/4407.html HOUSTON, May 29 (UPI) -- A Texas appellate court Thursday rejected a $26.1 million award given to a woman for the death of her husband who was on the once-popular pain reliever Vioxx. Link to original article http://www.vioxxadvisor.com/4403.html A Houston appellate court today overturned a multimillion-dollar 2005 Angleton jury finding that a 59-year-old triathlete died because of his use of the painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4401.html W. Mark Lanier, the Houston plaintiffs lawyer who won a $234.4 million jury verdict in the nation's first Vioxx trial, isn't mincing words; he calls Thursday's Texas appeals court opinion reversing a $26.1 million judgment in that suit "judicial activism for corporate America." Lanier says he will appeal the Texas ... http://www.vioxxadvisor.com/4402.html The major victories for Merck pushed the litigation over Vioxx closer to conclusion and highlighted the difficulty that plaintiffs’ lawyers are having in winning lawsuits against big drug companies. Click here for more info http://www.vioxxadvisor.com/4400.html BOSTON (MarketWatch) -- A Texas appeals court has overturned what had initially been a staggering award against Merck & Co. over the marketing of its now-recalled painkiller Vioxx. ... http://www.vioxxadvisor.com/4398.html Appeals courts in New Jersey and Texas have scrapped verdicts against drugmaker Merck stemming from some of the earliest trials involving its once popular painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4399.html Appeals courts in New Jersey and Texas on Thursday scrapped verdicts against the drugmaker Merck stemming from some of the earliest trials involving its once popular painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4393.html A Texas appeals court reversed a $26.1 million decision against Merck, finding that its Vioxx painkiller did not cause the fatal heart attack suffered by a plaintiff's husband. More... http://www.vioxxadvisor.com/4394.html NEWARK, N.J. — A Texas appeals court has scrapped a $26-million verdict against the drugmaker Merck stemming from the first trial involving its once popular painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4395.html A Texas appeals court throws out a $26 million verdict against the drugmaker Merck in a case involving Vioxx. Click here for more info http://www.vioxxadvisor.com/4396.html Appeals courts in New Jersey and Texas today scrapped verdicts against the drugmaker Merck & Co. Inc. stemming from some of the earliest trials involving its once popular painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4397.html NEWARK, N.J. - Appeals courts in Texas and New Jersey on Thursday scrapped verdicts against the drugmaker Merck & Co. Inc. stemming from some of the earliest trials involving its once popular painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4390.html Appeals courts in New Jersey and Texas have scrapped verdicts against the drugmaker Merck stemming from some of the earliest trials involving its painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4391.html Appeals courts in New Jersey and Texas on Thursday scrapped verdicts against the drugmaker Merck & Co. Inc. stemming from some of the earliest trials involving its once popular painkiller Vioxx, including one in Keene. Link to original article http://www.vioxxadvisor.com/4392.html A South Texas jury found Merck & Co. liable for the death of a 71-year-old man and ordered the company to pay $32 million. More... http://www.vioxxadvisor.com/4385.html Associated Press - May 29, 2008 10:23 AM ET NEWARK, N.J. (AP) - A Texas appeals court has scrapped a $26 million verdict against the drugmaker Merck stemming from the first trial involving its Link to original article http://www.vioxxadvisor.com/4388.html Texas appeals court's decision stems from first trial involving Merck's once popular painkiller Read more here http://www.vioxxadvisor.com/4389.html Appeals courts in New Jersey and Texas have scrapped verdicts against drugmaker Merck stemming from some of the earliest trials involving its once popular painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4386.html Merck & Co said on Thursday a Texas appeals court reversed a decision against the company in the first trial involving alleged injuries caused by its withdrawn Vioxx painkiller. More... http://www.vioxxadvisor.com/4387.html A California jury on Wednesday cleared pharmaceutical company Merck & Co. of liability in the case of an elderly Northridge man who claimed his heart ailments were caused by the drug maker's once-popular painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4384.html http://www.vioxxadvisor.com/4383.html Hawaii's share of a $58 million multistate settlement with Vioxx drug maker Merck & Co. is $1.1 million, said state Office of Consumer Protection Executive Director Stephen Levins. Click here for more info http://www.vioxxadvisor.com/4382.html Merck & Co., Inc. has reached civil settlements with Attorneys General from 29 states and the District of Columbia to fully resolve previously disclosed investigations under state consumer protection laws related to past activities for Vioxx. Link to original article http://www.vioxxadvisor.com/4381.html Pierre - South Dakota will receive a little more than $1 million from a 30-state legal settlement with Merck and Co., Attorney General Larry Long said Wednesday. South Dakota and 29 other states went to court against the drug giant because of concerns about deceptive promotion of the painkiller Vioxx. ... http://www.vioxxadvisor.com/4380.html Drug giant Merck has agreed to pay Connecticut $1.35 million for deceptive marketing of its once popular painkilling drug Vioxx as part of a national $58 million settlement between Merck, 29 states, and the District of Columbia. Read more here http://www.vioxxadvisor.com/4379.html Texas and 28 other states will share a $58 million payment from pharmaceutical giant Merck & Co., which resolves longstanding claims that the company downplayed risks related to Vioxx, an anti-inflammatory drug that was linked to thousands of heart attack deaths. (MRK) Link to original article http://www.vioxxadvisor.com/4378.html Deceptive promotion of the drug Vioxx is costing drug company Merck $58 million in a judgment with 30 states, including $1.15 million that's going to Idaho. Click here for more info http://www.vioxxadvisor.com/4376.html Merck to pay out $58 million over television ads Merck & Co. has agreed to pay $58 million to multiple states, including Maryland, to settle allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks. ... http://www.vioxxadvisor.com/4377.html New Jersey will receive $1.8 million as part of the $58 million Merck & Co. agreed to pay as a portion of a multistate settlement of allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks. Click here for more info http://www.vioxxadvisor.com/4374.html Merck & Co. has agreed to pay $58 million as part of a multistate settlement of allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks.The agreement announced Tuesday also calls for Merck to submit all new TV commercials for its drugs to the Food ... http://www.vioxxadvisor.com/4375.html HARRISBURG, Pa. -- Merck & Co. has agreed to pay $58 million as part of a multistate settlement of allegations that its ads for the once-popular painkiller Vioxx deceptively played down risks. The agreement announced yesterday also calls for Merck to submit all new TV commercials for its drugs to ... http://www.vioxxadvisor.com/4372.html Efforts to bring more scrutiny to drug research and promotion got a boost Tuesday when Merck settled claims from 29 states and the District of Columbia that it misled consumers in advertisements for its painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4373.html HARRISBURG, Pa. - Merck & Co. has agreed to pay $58 million as part of a multistate settlement of allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks. Read more here http://www.vioxxadvisor.com/4368.html Merck & Co. has agreed to pay $58 million to 29 states, including Kansas, to settle deceptive marketing claims involving Vioxx. More... http://www.vioxxadvisor.com/4369.html Merck & Co. has agreed to pay $58 million as part of a multistate settlement of allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks. The agreement announced Tuesday also calls for Merck to submit new TV commercials for its drugs to the Food ... http://www.vioxxadvisor.com/4370.html Washington will receive $1.6 million of a $58 million settlement from Merck & Co. over the marketing of the painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4371.html Merck agreed yesterday to a $58 million settlement with 29 states and the District of Columbia over advertising for the withdrawn painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4367.html Washington will receive $1.6 million of a $58 million settlement from Merck & Co. over the marketing of the painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4366.html Pennsylvania, New Jersey, 27 other states and the District of Columbia have reached a $58 million settlement with Merck over allegations that the company used deceptive practices to market the drug Vioxx. It's being called the largest-eversettlement for a multi-state consumer protection drug case. Link to original article http://www.vioxxadvisor.com/4364.html HARRISBURG, Pa. — Merck & Co. is paying $58 million as part of a multistate settlement concerning advertising of the now-withdrawn painkiller, Vioxx. More... http://www.vioxxadvisor.com/4365.html Merck & Co. is paying $58 million as part of a multistate settlement concerning advertising of the now-withdrawn painkiller, Vioxx, which addresses allegations that the New Jersey-based company deceptively downplayed the drug's health risk. Link to original article http://www.vioxxadvisor.com/4360.html HARRISBURG, Pa. (NEWS CENTER/AP) -- The civil settlement ends investigations by 29 states, including Maine, into Merck's advertising practices involving Vioxx. More... http://www.vioxxadvisor.com/4361.html http://www.vioxxadvisor.com/4362.html SAN FRANCISCO (Thomson Financial) - Merck & Co. will pay $58 million to 29 states and the District of Columbia to settle allegations of deceptive advertising related to its painkiller Vioxx, Pennsylvania's attorney general said Tuesday. Read more here http://www.vioxxadvisor.com/4363.html RIO GRANDE CITY -- A state appeals court overturned a Starr County jury's landmark verdict Wednesday against the makers of the painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4359.html SAN ANTONIO, May 16 (UPI) -- The Texas Fourth Court of Appeals overturned a $7.75 million verdict against Merck & Co. in a lawsuit over the heart risk of the painkiller Vioxx. More... http://www.vioxxadvisor.com/4358.html A Texas appeals court has overturned a multimillion-dollar verdict against Merck, the former maker of Vioxx. Read more here http://www.vioxxadvisor.com/4357.html TRENTON, N.J. — A Texas appeals court on Wednesday overturned a multimillion-dollar verdict against Merck & Co. in one of the few trials it lost over its withdrawn painkiller Vioxx. A jury in Rio Grande City, Texas, in April 2006 awarded $32 million to the widow of Leonel Garza, ... http://www.vioxxadvisor.com/4356.html A Texas appeals court on Wednesday overturned a multimillion-dollar verdict against Merck & Co. in a case involving its withdrawn painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4354.html TRENTON, N.J. (AP) - A Texas appeals court today overturned a multimillion-dollar verdict against Merck in a case over its withdrawn painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4355.html 14/05/2008 19:27:00 Business Wire Merck & Co., Inc. said today a Texas appellate court overturned the April 2006 verdict of a state court jury in Starr County, Texas, in the VIOXX product liability case Garza v. Read more here http://www.vioxxadvisor.com/4352.html TRENTON, N.J. (AP) - A Texas appeals court overturns a verdict that Merck & Co. lost in the Vioxx case. A Texas jury two years ago awarded the widow of 71-year-old Leonel Garza $32 million. That later was cut to about $7.75 million under Texas damage caps. Read more here ... http://www.vioxxadvisor.com/4353.html The case involves a jury award to the widow of a 71-year-old man who had a history of heart disease and died of a heart attack after taking Vioxx briefly. More... http://www.vioxxadvisor.com/4346.html A Texas appeals court on Wednesday overturned a multimillion-dollar verdict against Merck & Co. in a case involving its withdrawn painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4348.html An appeals court in Texas overturned a $7.75 million verdict against Merck & Co involving its withdrawn pain drug Vioxx on Wednesday, ruling that evidence presented at trial failed to prove the medicine caused the heart attack suffered by the plaintiff's husband. Click here for more info http://www.vioxxadvisor.com/4349.html A Texas appeals court has overturned a verdict that Merck & Co. lost in the Vioxx case. Click here for more info http://www.vioxxadvisor.com/4350.html Readington-based Merck & Co. says a Texas appeals court has overturned a verdict against the drugmaker in a case involving its withdrawn painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4351.html TRENTON, N.J. -- A Texas appeals court overturns a verdict that Merck and Co. lost in the Vioxx case. A Texas jury two years ago awarded the widow of 71-year-old Leonel Click here for more info http://www.vioxxadvisor.com/4345.html An appeals court overturned a verdict that Merck & Co. lost in the Vioxx case. More... http://www.vioxxadvisor.com/4347.html Americas Watchdog has just launched a national investigation into seeing if consumers, HMO's, health insurance companies, or health cooperatives were over charged with the drug called Vioxx, Trasylol or any other drugs, when much cheaper alternatives were available. Read more here http://www.vioxxadvisor.com/4344.html Merck & Co., Inc. said at least 94 per cent of eligible US claimants have elected to participate in its $4.85 billion Vioxx settlement and has extended until June 30 the deadline for registered participants to submit paperwork. Link to original article http://www.vioxxadvisor.com/4343.html Merck & Co said on Thursday at least 94 percent of eligible U.S. claimants have elected to participate in its $4.85 billion proposed Vioxx settlement, and the drugmaker extended the deadline for the remainder to join in. Read more here http://www.vioxxadvisor.com/4342.html Merck & Co., Inc. said today it has extended to June 30, 2008, the enrollment deadline for U.S. eligible Read more here http://www.vioxxadvisor.com/4341.html http://www.vioxxadvisor.com/4340.html Americas Watchdog has just launched a national investigation into seeing if HMO's, health insurance companies, or health cooperatives were over charged with the drug called Vioxx, when much cheaper alternatives were available. More... http://www.vioxxadvisor.com/4339.html A Merck’s internal communication talks of the drug being associated with an increased risk of causing deaths Link to original article http://www.vioxxadvisor.com/4338.html Two new reports involving the painkiller Vioxx raise fresh concerns about how drug companies influence the interpretation and publication of medical research. More... http://www.vioxxadvisor.com/4337.html The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S. Link to original article ... http://www.vioxxadvisor.com/4336.html N Maker of Vioxx facing multi-billion-dollar settlement over pain killer also More... http://www.vioxxadvisor.com/4335.html Merck, in the process of settling litigation over its withdrawn painkiller Vioxx, got hit with some new problems during the first quarter. Read more here http://www.vioxxadvisor.com/4334.html Sen. Chuck Grassley (R-Iowa) has sent a letter to Merck Chief Operating Officer Richard Clark requesting the company explain a recent report that found the company used employees or paid consultants rather than the physicians listed as lead authors to write several published studies of the COX-2 inhibitor Vioxx, CQ ... http://www.vioxxadvisor.com/4333.html Claims that the pharmaceutical company Merck hired ghostwriters for Vioxx articles has put heat on a U.S. proposal to loosen drug promotion rules. Read more here http://www.vioxxadvisor.com/4332.html Aetna Inc., Humana Inc., and more than 40 other providers of health insurance and managed-care plans sued the administrators of Merck & Co.'s $4.85 billion Vioxx settlement fund to determine who will get the money. More... http://www.vioxxadvisor.com/4331.html A report indicating that Merck used ghostwriters to produce articles in support of its drug Vioxx has galvanized opponents to a proposal that would relax some restrictions on drug promotion. More... http://www.vioxxadvisor.com/4330.html Merck employees or paid consultants, rather than the physicians listed as lead authors, wrote several published studies of the COX-2 inhibitor Vioxx, and the company downplayed evidence that the medication tripled risk for death in patients with Alzheimer's disease, according to two reports published on Wednesday in the Journal of ... http://www.vioxxadvisor.com/4329.html Pharmaceutical company Merck knew in 2001 that its arthritis drug Vioxx could harm patients and used staffers to "ghostwrite" favorable research on the drug, articles in the Journal of the American Medical Association report. Susan Dentzer examines the charges. Link to original article http://www.vioxxadvisor.com/4327.html WASHINGTON - Two teams of researchers with access to thousands of documents gathered in lawsuits over the painkiller Vioxx allege that Merck & Co. waged a campaign of deception to promote its drug, moving slowly to warn of possible hazards while at the same time dressing up in-house research as ... http://www.vioxxadvisor.com/4328.html Title: Vital Vioxx Details 'Manipulated' Category: Health News Created: 4/16/2008 Last Editorial Review: 4/16/2008 Read more here http://www.vioxxadvisor.com/4326.html Drugmaker Merck drafted dozens of research studies for its best-selling pain drug Vioxx, then lined up prestigious doctors to put their names on the reports, according to a leading medical journal. Read more here http://www.vioxxadvisor.com/4325.html Two new reports involving the painkiller Vioxx raise fresh concerns about how drug companies influence the interpretation and publication of medical research. The reports claim Merck & Co. frequently paid academic scientists to take credit for research ... http://www.vioxxadvisor.com/4323.html Merck & Co Inc suppressed evidence that its withdrawn arthritis pill Vioxx could harm patients, US researchers allege. More... http://www.vioxxadvisor.com/4324.html Merck played down the risk of death linked to the US pharmaceutical giant's anti-inflammatory drug Vioxx in trial studies the company made public, according to a study released Tuesday. Read more here http://www.vioxxadvisor.com/4322.html Two new reports involving the painkiller Vioxx raise fresh concerns about how drug companies influence the interpretation and publication of medical research. More... http://www.vioxxadvisor.com/4321.html MERCK & Co Inc suppressed evidence that its withdrawn arthritis pill Vioxx could harm patients, US researchers charged today. More... http://www.vioxxadvisor.com/4320.html TUESDAY, April 15 (HealthDay News) -- Industry documents reveal that pharmaceutical giant Merck & Co. paid academics to put their names on Vioxx research published in top medical journals while company employees often ghost-wrote the studies on the controversial cox-2 painkiller. Click here for more info http://www.vioxxadvisor.com/4317.html Two teams of researchers with access to thousands of documents gathered in lawsuits over the painkiller Vioxx allege that Merck & Co. waged a campaign of deception to promote its drug, moving slowly to warn of possible hazards while dressing up in-house research as the work of independent academic ... http://www.vioxxadvisor.com/4318.html A new controversy is brewing Tuesday over Merck and its embattled drug, Vioxx. Click here for more info http://www.vioxxadvisor.com/4319.html Merck and Co. may have misrepresented the risks of its now-withdrawn pain drug Vioxx and allowed a trial of the drug to continue for two years even though it knew it might be harming patients, U.S. researchers said on Tuesday. More... http://www.vioxxadvisor.com/4308.html Merck & Co Inc suppressed evidence that its withdrawn arthritis pill Vioxx could harm patients, U.S. researchers charged on Tuesday. Click here for more info http://www.vioxxadvisor.com/4309.html The risk of death linked to Merck's anti-inflammatory drug Vioxx was minimized in trial studies the company made public, according to a study out Tuesday. More... http://www.vioxxadvisor.com/4310.html April 15 (Bloomberg) -- Merck & Co . hired ghostwriters to pen reports about the pain pill Vioxx, allegedly allowing the company to manipulate scientific articles to promote the drug, according to a new analysis of court records. Read more here http://www.vioxxadvisor.com/4311.html Newly released legal documents spell out what Merck knew about Vioxx and when they knew it. Link to original article http://www.vioxxadvisor.com/4312.html There is new information about the drug Vioxx that was pulled from the market in 2004. Click here for more info http://www.vioxxadvisor.com/4313.html The maker of the controversial arthritis drug Vioxx knew of its dangers for as long as three years before a massive nationwide recall, but withheld the information and played down the number of deaths associated with the pain medication, according to an analysis published today by University of Washington professors. ... http://www.vioxxadvisor.com/4314.html CHICAGO - Two new reports involving the painkiller Vioxx raise fresh concerns about how drug companies influence the interpretation and publication of medical research. Click here for more info http://www.vioxxadvisor.com/4315.html The article, based on documents unearthed in lawsuits over the pain drug Vioxx, provides a rare, detailed look in the industry practice of ghostwriting medical research studies that are then published in academic journals. More... http://www.vioxxadvisor.com/4316.html CBS News reports Vioxx was one of the most popular anti-inflammatory drugs on the market, but it was quickly pulled from store shelves once several deaths were linked to it. Link to original article http://www.vioxxadvisor.com/4307.html NEW ORLEANS (Reuters) - More than 3,000 former users of Merck & Co's withdrawn Vioxx pain drug have already signed up to take part in a $4.85 billion settlement deal that a federal judge on Friday declared was in the best interests of both sides. ... http://www.vioxxadvisor.com/4306.html Richard Clark is used to chal lenges by now. As chief executive of Merck, Clark tackled a top-to-bottom restructuring of the Whitehouse Station-based drugmaker, steered the company through vex ing Vioxx court battles and guided the development of blockbuster cervical-cancer vaccine Gardasil. Click here for more info http://www.vioxxadvisor.com/4305.html On Monday, drug maker Merck's stock opened at its lowest point since the company pulled painkiller Vioxx off the market four years ago. This time the problem is Vytorin, a cholesterol-lowering medication that includes the drug Zetia. Read more here http://www.vioxxadvisor.com/4304.html Merck & Co. Inc. today saw the largest daily drop in its stock value since the pain reliever Vioxx was withdrawn in the fall of 2004. More... http://www.vioxxadvisor.com/4303.html WASHINGTON - Vioxx, Bextra, Rezulin, Baycol. Looking at drugs yanked off the market, Harvard researchers found a disturbing pattern: Medicines approved right on deadline by the Food and Drug Administration are more likely to cause safety problems later than those cleared with more time to spare. More... http://www.vioxxadvisor.com/4302.html The agency recently began notifying the public earlier about possible safety issues. The policy change came after the FDA was criticized for acting too slowly on information about the risks of Merck's painkiller Vioxx and, GlaxoSmithKline plc 's diabetes pill Avandia . Click here for more info http://www.vioxxadvisor.com/4301.html WASHINGTON - Vioxx, Bextra, Rezulin, Baycol. Looking at drugs yanked off the market, Harvard University researchers found a disturbing pattern: Medicines approved right on deadline by the Food and Drug Administration are more likely to cause safety problems later on than those cleared with more time to spare. Read more ... http://www.vioxxadvisor.com/4300.html WASHINGTON | Vioxx, Bextra, Rezulin, Baycol. Looking at drugs yanked off the market, Harvard researchers found a disturbing pattern: Click here for more info http://www.vioxxadvisor.com/4299.html Vioxx, Bextra, Rezulin, Baycol. Looking at drugs yanked off the market, Harvard researchers found a disturbing pattern: Medicines approved right on deadline by the Food and Drug Administration are more likely to cause safety problems later than those cleared with more time to spare. More... http://www.vioxxadvisor.com/4298.html People who think their heart attacks or strokes were caused by the once-popular painkiller Vioxx and want early partial payments now have an additional month to file paperwork backing up their claims under a settlement with manufacturer Merck & Co. More... http://www.vioxxadvisor.com/4296.html People who think their heart attacks or strokes were caused by the once-popular painkiller Vioxx now have until May 1 to file the paperwork to back up their claims under a settlement with Readington-based manufacturer Merck & Co. Click here for more info http://www.vioxxadvisor.com/4297.html People who think their heart attacks or strokes were caused by a once-popular painkiller now have another month to file the paperwork to back up their claims. More... http://www.vioxxadvisor.com/4295.html Tens of thousands are eligible to share in settlement. They claim stroke and heart attacks caused by the medicine. more Read more here http://www.vioxxadvisor.com/4294.html NEW ORLEANS -- People who think their heart attacks or strokes were caused by the once-popular painkiller Vioxx and want early partial payments now have another month to file paperwork Read more here http://www.vioxxadvisor.com/4292.html People who think their heart attacks or strokes were caused by the once-popular painkiller Vioxx now have another month to file the paperwork to back up their claims. more Click here for more info http://www.vioxxadvisor.com/4293.html People who think their heart attacks or strokes were caused by the once-popular painkiller Vioxx now have another month to file the paperwork to back up their claims under a settlement with manufacturer Merck & Company. Read more here http://www.vioxxadvisor.com/4291.html NEW ORLEANS People who think their heart attacks or strokes were caused by the once-popular painkiller Vioxx now have another month to file the paperwork to back up their claims under a settlement with manufacturer Merck & Company. Click here for more info http://www.vioxxadvisor.com/4290.html If one company's disaster can transform an industry, the withdrawal of Merck's $2.5 billion painkiller Vioxx in 2004 may become the textbook example. Primarily, the removal of Vioxx from the market due to heart risks spurred a sweeping examination of the ... http://www.vioxxadvisor.com/4289.html The chief executive of Merck, Richard T. Clark, received compensation valued at $14.5 million in 2007, despite Merck’s $4.85 billion loss to settle Vioxx litigation. Link to original article http://www.vioxxadvisor.com/4288.html TRENTON, N.J. - Merck & Co.'s chief executive officer, Richard T. Clark, got compensation valued at $14.5 million in 2007, an 80 percent raise in a year when the drugmaker took a $4.85 billion charge to settle much of the litigation over its former painkiller Vioxx. Link to original article ... http://www.vioxxadvisor.com/4287.html Merck & Co.'s chief executive officer, Richard T. Clark, got compensation valued at $14.5 million in 2007, an 80 percent raise in a year when the drugmaker took a $4.85 billion charge to settle much of the litigation over its former painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4286.html Merck's chief executive, Richard Clark, got compensation valued at $14.5 million in 2007, an 80 percent raise in a year when the drugmaker took a $4.85 billion charge to settle much of the litigation over its former painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4285.html The chief executive of Merck, Richard T. Clark, received compensation valued at $14.5 million in 2007, despite Merck?s $4.85 billion loss to settle Vioxx litigation. Read more here http://www.vioxxadvisor.com/4284.html The head of the New Jersey based drugmaker compensated $14.5M in 2007, a year when the company took a $4.85B charge to settle its Vioxx litigation. Read more here http://www.vioxxadvisor.com/4283.html Merck & Co.'s chief executive officer, Richard T. Clark, got compensation valued at $14.5 million in 2007, an 80 percent raise in a year when the drugmaker took a $4.85 billion charge to settle much of the litigation over its former painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4282.html TRENTON -- Merck & Co. is on the verge of settling its most serious personal injury lawsuits over Vioxx, but the drugmaker still faces substantial litigation over the onetime blockbuster painkiller it yanked from the market in 2004 because of cardiovascular risks. Click here for more info http://www.vioxxadvisor.com/4281.html Merck & Co. is on the verge of settling most serious personal injury lawsuits over Vioxx, but the drugmaker still faces substantial litigation over the one-time blockbuster painkiller it yanked from the market in 2004 because of cardiovascular risks. ... http://www.vioxxadvisor.com/4280.html A $4.5 billion settlement hasn't slowed new lawsuits over Vioxx. Link to original article http://www.vioxxadvisor.com/4279.html TRENTON, N.J. – Merck and Co. is on the verge of settling most serious personal injury lawsuits over Vioxx, but the drugmaker still faces substantial litigation over the one-time blockbuster painkiller it yanked from the market in 2004 because of cardiovascular risks. Read more here http://www.vioxxadvisor.com/4278.html TRENTON, N.J. — Merck & Co. is on the verge of settling most serious personal injury lawsuits over Vioxx, but the drugmaker still faces substantial litigation over the one-time blockbuster painkiller it yanked from the market in 2004 because of Link to original article http://www.vioxxadvisor.com/4276.html Merck is on the verge of settling most of the serious personal injury lawsuits over Vioxx, but the drugmaker still faces substantial litigation over the one-time blockbuster painkiller it yanked from the market in 2004 because of cardiovascular risks. Click here for more info http://www.vioxxadvisor.com/4277.html TRENTON, N.J. — Merck & Co. is on the verge of settling most serious personal injury lawsuits over Vioxx, but the drugmaker still faces substantial litigation over the one-time Read more here http://www.vioxxadvisor.com/4274.html Merck & Co. is on the verge of settling most serious personal injury lawsuits over Vioxx, but the drugmaker still faces substantial litigation over the one-time blockbuster painkiller it yanked from the market in 2004 because of cardiovascular risks. More than 44,000 plaintiffs have enrolled in a proposed $4.85 billion ... http://www.vioxxadvisor.com/4275.html Merck & Co. is on the verge of settling most serious personal injury lawsuits over Vioxx, but the drugmaker faces lots of litigation over the onetime blockbuster painkiller it yanked from the market in 2004 over cardiovascular risks. ... http://www.vioxxadvisor.com/4273.html Responsibilities Include Deciding Claimant Appeals Click here for more info http://www.vioxxadvisor.com/4270.html Merck is on the verge of settling most serious personal injury lawsuits over Vioxx, but it still faces substantial litigation. Click here for more info http://www.vioxxadvisor.com/4271.html More than 44,000 plaintiffs have enrolled in a proposed $4.85 billion settlement for U.S. personal injury cases involving a heart attack, stroke or death, the company said this week. Click here for more info http://www.vioxxadvisor.com/4272.html Merck & Co. is on the verge of settling most serious personal injury lawsuits over Vioxx, but the drugmaker still faces substantial litigation over the one-time blockbuster painkiller it yanked from the market in 2004 because of cardiovascular risks. Link to original article http://www.vioxxadvisor.com/4269.html The former chairman and CEO of the pharmaceutical giant Merck, Roy P. Vagelos , has bought a $21 million condo at 15 Central Park West, city records today show. At Merck until 1994, Mr. Vagelos was largely credited with sheperding the firm through its pre-Vioxx golden years. Since ... http://www.vioxxadvisor.com/4267.html The rheumatoid arthritis treatment market, held back somewhat in recent years by generic competition and the withdrawal of Vioxx and Bextra, is rebounding due to the performance of biologic treatments. Click here for more info http://www.vioxxadvisor.com/4268.html The pharmaceutical company Merck says it's ready to settle claims with more than 44,000 former Vioxx users. Merck agreed to hand out $4.85 billion if 85 percent of the potential claimants registered by last Friday, and Merck says it's received enough paperwork to move forward. Link to original article http://www.vioxxadvisor.com/4266.html A nearly five billion dollar settlement over the withdrawn painkiller Vioxx is on the track to move out to thousands of affected consumers. Drug company, Merck says more then 44,000 people have signed up to take part in the deal by submitting medical records and other documents. More... http://www.vioxxadvisor.com/4265.html More than 44,000 people have signed up for shares of a $4.85 billion settlement over the withdrawn painkiller Vioxx, a sign that the deal is on track to go forward, Merck & Co. announced Monday. Of roughly 47,000 people who registered for the settlement earlier this year, more than 44,000 ... http://www.vioxxadvisor.com/4264.html A proposed $4.8 billion agreement crafted to settle a majority of the remaining Vioxx-related lawsuits against Merck has drawn more than 44,000 plaintiffs, meeting a critical early requirement for the settlement to go into effect. Link to original article http://www.vioxxadvisor.com/4263.html More than 44,000 people have signed up for shares of a $4.85 billion settlement over the withdrawn painkiller Vioxx, a sign that the deal is on track to go forward, Merck & Co. announced Monday More... http://www.vioxxadvisor.com/4261.html More than 44,000 people have signed up for a piece of a $4.85 billion settlement over the withdrawn painkiller Vioxx, a sign that the deal is on track to go forward. More... http://www.vioxxadvisor.com/4262.html A nearly $5 billion settlement over the withdrawn painkiller Vioxx is on track to move forward. Merck says more than 44,000 people have signed up to take part in the deal by submitting medical records and other necessary paperwork. Read more here http://www.vioxxadvisor.com/4260.html More than 44,000 people have signed up for shares of a $4.85 billion settlement over the withdrawn painkiller Vioxx, a sign that the deal is on track to go forward, Merck & Co. announced Monday. Read more here http://www.vioxxadvisor.com/4259.html Merck & Co on Monday said it has moved closer to resolving thousands of claims arising from its 2004 withdrawal of arthritis pill Vioxx, with 93 percent of people alleging the drug caused a heart attack or stroke submitting documents in a $4.85 billion settlement. Click here for more info ... http://www.vioxxadvisor.com/4258.html Merck said that more than 93 percent of the 47,000 people who allege that the arthritis drug Vioxx caused their heart attack or stroke have submitted claims in the company’s settlement offer. More... http://www.vioxxadvisor.com/4256.html NEW YORK (Thomson Financial) - Merck & Co. Monday said more than 44,000 of the 47,000 people who registered eligible injuries have submitted some or all of the material for enrollment that could qualify them for an interim payment in the program to resolve legal claims filed against the company ... http://www.vioxxadvisor.com/4257.html NEW YORK (MarketWatch) -- Merck & Co. said Monday that more than 44,000 of the 47,000 Vioxx patients who claim unhealthy side-effects from the pain reliever filed "some or all" of the paperwork needed to participate in a $4.85 billion settlement. ... http://www.vioxxadvisor.com/4255.html NEW ORLEANS -- More than 44,000 people have signed up for shares of a $4.85 billion settlement over the withdrawn painkiller Vioxx, a sign that the deal is on track to go forward, More... http://www.vioxxadvisor.com/4252.html Merck & Co. Inc. said Monday it continues to make progress on its $4.85 billion Vioxx settlement agreement. (MRK) Click here for more info http://www.vioxxadvisor.com/4253.html More than 44,000 people have signed up for shares of a $4.85 billion settlement over the withdrawn painkiller Vioxx, a sign that the deal is on track to go forward, Merck & Co. announced Monday. Click here for more info http://www.vioxxadvisor.com/4254.html http://www.vioxxadvisor.com/4246.html NEW YORK (Thomson Financial) - Merck & Co. Monday said more than 44,000 of the 47,000 people who registered eligible injuries have submitted some or all of the material for enrollment that could qualify them for an interim payment in the program to resolve legal claims filed against the company ... http://www.vioxxadvisor.com/4247.html Associated Press - March 3, 2008 8:44 AM ET NEW ORLEANS (AP) - More than 44,000 people have signed up for shares of a $4.85 billion settlement over the withdrawn painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4248.html http://www.vioxxadvisor.com/4249.html More than 44,000 people have signed up for shares of a $4.85 billion settlement over the withdrawn painkiller Vioxx. Merck & Company says those enrollment figures, released Monday, indicate that the settlement is on track to proceed. Merck says that of the roughly 47,000 people who registered for the settlement, ... http://www.vioxxadvisor.com/4250.html The drugmaker Merck says more than 44,000 people have signed up for part of a $4.85 billion settlement over the withdrawn painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4251.html Justices could shield FDA-backed drugs from suits, as they did for devices. Critics say the agency is fallible. Years of high-profile court battles over drugs such as Vioxx and Celebrex, along with billion-dollar settlements and jury verdicts, could soon be a thing of the past. ... http://www.vioxxadvisor.com/4245.html The coffers of the Missouri Medicaid program grew by $3.1 million through a settlement over a fraud complaint against pharmaceutical maker Merck, Missouri Attorney General Jay Nixon announced today. The settlement resolves allegations Merck shortchanged rebates paid to the Medicaid program for Zocor and Vioxx. The total settlement came to ... http://www.vioxxadvisor.com/4244.html Lawyers will have an extra month to send in paperwork for people who want early payment from a $4.85 billion federal court settlement involving the painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4243.html Associated Press - February 21, 2008 4:44 PM ET NEW ORLEANS (AP) - Lawyers will have an extra month to send in paperwork for people who want early payment from a $4.85 billion federal court Click here for more info http://www.vioxxadvisor.com/4242.html REGINA - A Saskatchewan court has certified a class-action lawsuit against the makers of the painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4241.html http://www.vioxxadvisor.com/4240.html Pharmaceutical giant Merck has agreed to pay a whopping $650 million in fines to the federal government. The case involves Merck routinely overbilling Medicaid for eight years for some of its most-prescribed medications, such as the arthritis drug Vioxx and cholesterol fighter Zocor. More... http://www.vioxxadvisor.com/4239.html Philadelphia law firm Dechert has cut its stable of contract attorneys almost in half, legal recruiters say, as the Vioxx products liability case they were involved in winds down. About 75 lawyers were looking for work, in many cases after three years of stable employment. Click here for more info ... http://www.vioxxadvisor.com/4238.html A sales manager who "just couldn't abide" by the way Merck wanted him to market the drugs Vioxx and Zocor to doctors took the lonely step of filing a whistleblower suit against his employer. Seven years later, Merck & Co. will pay $671 million to settle complaints it overcharged government ... http://www.vioxxadvisor.com/4237.html PHILADELPHIA - Merck & Co. has agreed to pay $671 million to settle claims that it overcharged Medicaid programs for two big-selling drugs, Vioxx and Zocor, and to resolve allegations of improper marketing to doctors, U.S. prosecutors and company officials announced Thursday. More... http://www.vioxxadvisor.com/4235.html Philadelphia | A sales manager who "just couldn't abide" by the way Merck wanted him to market the drugs Vioxx and Zocor to doctors took the lonely step of filing a whistleblower suit against his employer. More... http://www.vioxxadvisor.com/4236.html A sales manager who "just couldn't abide" by the way Merck wanted him to market the drugs Vioxx and Zocor to doctors took the lonely step of filing a whistle-blower suit against his employer. More... http://www.vioxxadvisor.com/4234.html A sales manager who "just couldn't abide" the way Merck wanted him to market the drugs Vioxx and Zocor to doctors took the lonely step of filing a whistle-blower lawsuit against his employer. Seven years later, Merck & Co. will pay $671 million to settle ... http://www.vioxxadvisor.com/4233.html PHILADELPHIA -- A sales manager who "just couldn't abide" by the way Merck wanted him to market the drugs Vioxx and Zocor to doctors took the lonely step of filing a whistleblower suit More... http://www.vioxxadvisor.com/4232.html Drug company, reeling from nine-figure settlements for Vioxx, Vytorin, and Zetia, agrees to stump up another $650 million in a new case. Read more here http://www.vioxxadvisor.com/4230.html A sales manager who "just couldn't abide" by the way Merck wanted him to market the drugs Vioxx and Zocor to doctors took the lonely step of filing a whistleblower suit against his employer. Seven years later, Merck & Co. will pay $671 million to ... http://www.vioxxadvisor.com/4231.html Merck and Co. has agreed to pay $671 million to settle claims that it overcharged Medicaid programs for four drugs, including Vioxx and Zocor, and to resolve allegations of improper marketing to doctors, U.S. prosecutors and company officials announced Thursday. Link to original article http://www.vioxxadvisor.com/4229.html PHILADELPHIA - U.S. prosecutors say Merck & Co. has agreed to pay $671 million to settle claims that it overcharged Medicaid programs for two big-selling drugs, Vioxx and Zocor. Click here for more info http://www.vioxxadvisor.com/4228.html PHILADELPHIA, PA -- Merck has agreed to pay $671 million to settle claims that it overcharged Medicaid programs for two big-selling drugs, Vioxx and Zocor, and to resolve allegations of improper marketing to doctors, U.S. prosecutors and company officials announced today. Link to original article http://www.vioxxadvisor.com/4226.html Merck & Co agreed to pay more than $649 million to resolve litigation related to its cholesterol drug Zocor and painkiller Vioxx, a federal prosecutor said on Thursday. Link to original article http://www.vioxxadvisor.com/4227.html Merck & Co. has agreed to pay a total of $399 million to the federal government, 49 states and the District of Columbia to settle Medicaid fraud claims involving the company's withdrawn painkiller Vioxx and its anticholestrol drug Zocor, the U.S. Attorney's office in Philadelphia said today. Read more here ... http://www.vioxxadvisor.com/4223.html The company allegedly paid kickbacks to doctors to prescribe Vioxx. Read more here http://www.vioxxadvisor.com/4224.html Merck & Co. has agreed to pay $671 million to settle claims that it overcharged Medicaid programs for two big-selling drugs, Vioxx and Zocor, and to resolve allegations of improper marketing to doctors, U.S. prosecutors and company officials announced Thursday. Read more here http://www.vioxxadvisor.com/4225.html Readington-based Merck & Co. has agreed to pay $671 million to settle claims that it overcharged Medicaid programs for two big-selling drugs, Vioxx and Zocor, and to resolve allegations of improper marketing to doctors, U.S. prosecutors and company officials announced today. Link to original article http://www.vioxxadvisor.com/4222.html Merck & Co. has agreed to pay a combined total of $671 million to settle claims that it overcharged Medicaid programs for two big-selling drugs, Vioxx and Zocor, and to resolve allegations of improper marketing to doctor. More... http://www.vioxxadvisor.com/4221.html A federal grand jury in Massachusetts is investigating the alleged illegal promotion by Merck & Co. of the painkiller Vioxx, a report said.The U.S. Attorney's Office is probing Merck & Co. for allegedly promoting Vioxx, which came off the market in 2004, to medical professionals for purposes unauthorized by the ... http://www.vioxxadvisor.com/4220.html The Whitehouse Station drugmaker withdrew Vioxx from the market in 2004, after a study linked the drug to an elevated risk of heart attack or stroke. More... http://www.vioxxadvisor.com/4219.html TRENTON, N.J. — Merck & Co. posted a $1.63 billion fourth-quarter loss Wednesday as a whopping charge for its Vioxx litigation settlement dragged down results. More... http://www.vioxxadvisor.com/4217.html NEW ORLEANS (AP) - Hundreds of Florida residents who claim the painkiller Vioxx caused their strokes or heart attacks were squeezed out of a federal court settlement and should be included, their lawyers say. If the motion they filed in U.S. District Court succeeds, people in a half-dozen other states ... http://www.vioxxadvisor.com/4218.html Hundreds of Florida residents who claim the painkiller Vioxx caused their strokes or heart attacks were squeezed out of a federal-court settlement and should be included, their lawyers say. More... http://www.vioxxadvisor.com/4216.html TRENTON, N.J.– Merck & Co. posted a $1.63 billion (U.S.) fourth-quarter loss yesterday as whopping charges, mainly for its Vioxx litigation settlement, dragged down results – and share prices. Link to original article http://www.vioxxadvisor.com/4215.html BOSTON (Dow Jones) -- Merck & Co. swung to a fourth-quarter loss, mostly because of charges it recorded to settle the bulk of litigation stemming from the recall of its blockbuster pain reliever Vioxx. Read more here http://www.vioxxadvisor.com/4214.html Merck posted a $1.63 billion fourth-quarter loss on Wednesday as charges for its Vioxx litigation settlement dragged down results and share prices. Click here for more info http://www.vioxxadvisor.com/4213.html Merck swung to a net loss for the fourth quarter, on the US drugmaker’s big costs to resolve litigation including a $4.85bn settlement of lawsuits over its withdrawn painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4212.html Merck & Co. posted a $1.63 billion fourth-quarter loss Wednesday as a whopping charge for its Vioxx litigation settlement dragged down results. Read more here http://www.vioxxadvisor.com/4210.html BOSTON (Dow Jones) -- Merck & Co. reported a dramatic drop in fourth-quarter earnings early Wednesday, due primarily to massive accounting charges relating to the settlement of bulk of the litigation stemming from the recall of its blockbuster pain reliever Vioxx. Click here for more info http://www.vioxxadvisor.com/4211.html Merck & Co. on Tuesday posted a $1.63 billion loss in the fourth quarter as whopping charges, mainly for its Vioxx litigation settlement, dragged down results. More... http://www.vioxxadvisor.com/4209.html Readington-based Merck & Co. on Tuesday posted a $1.63 billion loss in the fourth quarter as whopping charges, mainly for its Vioxx litigation settlement, dragged down results.` More... http://www.vioxxadvisor.com/4207.html WHITEHOUSE STATION, N.J. - Merck & Co. on Tuesday posted a US$1.63-billion loss in the fourth quarter as whopping charges for its Vioxx litigation settlement and other items dragged down results. Click here for more info http://www.vioxxadvisor.com/4208.html WHITEHOUSE STATION, N.J.–Merck & Co. posted a $1.63 billion loss in the fourth quarter as whopping charges for its Vioxx litigation settlement and other items dragged down results. Read more here http://www.vioxxadvisor.com/4205.html Merck and Co on Wednesday reported a fourth-quarter loss due to a number of charges, including for a costly settlement related to its withdrawn Vioxx arthritis drug. Click here for more info http://www.vioxxadvisor.com/4202.html Jan. 30 (Bloomberg) -- Merck & Co., the third-largest U.S. drugmaker, reported a fourth-quarter loss after taking a $4.85 billion charge to settle lawsuits over its painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4203.html Merck & Co. reported a dramatic drop in fourth-quarter earnings early Wednesday, due primarily to massive accounting charges relating to the settlement of bulk of the litigation stemming from the recall of its blockbuster pain reliever Vioxx. ... http://www.vioxxadvisor.com/4204.html Merck & Co. (MRK) swung to a fourth-quarter loss on charges for settling the bulk of Vioxx liability cases, as the pharmaceuticals company saw strong sales growth of its allergy and cholesterol treatments. Read more here http://www.vioxxadvisor.com/4206.html Hundreds of Florida residents who claim the painkiller Vioxx caused their strokes or heart attacks were squeezed out of a federal court settlement and should be included, their lawyers say in a motion filed in U.S. District Court. Link to original article http://www.vioxxadvisor.com/4201.html NEW ORLEANS -- Hundreds of Florida residents who claim the painkiller Vioxx caused their strokes or heart attacks were squeezed out of a federal court settlement and should be included, Click here for more info http://www.vioxxadvisor.com/4200.html NEW ORLEANS -- Hundreds of Florida residents who claim the painkiller Vioxx caused their strokes or heart attacks were squeezed out of a federal court settlement and should be included, Link to original article http://www.vioxxadvisor.com/4199.html Hundreds of Florida residents who claim the painkiller Vioxx caused their strokes or heart attacks were squeezed out of a federal court settlement and should be included, their lawyers say in a motion filed in U.S. Click here for more info http://www.vioxxadvisor.com/4198.html Celebrex, an arthritis drug in the same class as the recalled painkiller Vioxx, caused irregular heartbeats in fruit flies and in heart cells taken from laboratory rats, U.S. researchers said on Friday. Click here for more info http://www.vioxxadvisor.com/4197.html Is an attorney?s fierce devotion to an individual client?s interests a passé concept? Click here for more info http://www.vioxxadvisor.com/4196.html A federal judge overseeing a $4.85 billion settlement with Merck & Co. over its withdrawn Vioxx painkiller expressed confidence Friday that lawyers have resolved ethical concerns about the agreement. Link to original article http://www.vioxxadvisor.com/4195.html A federal judge overseeing a $4.85 billion settlement with Merck & Co. over its withdrawn Vioxx painkiller expressed confidence Friday that lawyers have resolved ethical concerns about the agreement. Some lawyers for Vioxx patients have challenged a provision of the settlement that bars attorneys with clients who participate in the ... http://www.vioxxadvisor.com/4194.html A federal judge overseeing a $4.85 billion settlement with Merck & Co. over its withdrawn Vioxx painkiller expressed confidence Friday that lawyers have resolved ethical concerns about the agreement. Read more here http://www.vioxxadvisor.com/4192.html NEW ORLEANS - A federal judge overseeing a $4.85 billion settlement with Merck & Co. over its withdrawn painkiller Vioxx expressed confidence yesterday that lawyers had resolved ethical concerns about the agreement. Link to original article http://www.vioxxadvisor.com/4193.html A federal judge overseeing a $4.85 billion settlement with Merck & Co. over its withdrawn Vioxx painkiller expressed confidence Friday that lawyers have resolved ethical concerns about the agreement. Click here for more info http://www.vioxxadvisor.com/4190.html NEW ORLEANS (AP) - A federal judge overseeing a $4.9 billion settlement with Merck involving its withdrawn Vioxx painkiller is expressing confidence that lawyers have resolved ethical concerns about the agreement. Read more here http://www.vioxxadvisor.com/4191.html More than 3,000 former users of Merck & Co's withdrawn Vioxx pain drug have already signed up to take part in a $4.85 billion settlement deal that a federal judge said on Friday was in the best interests of both sides. Click here for more info http://www.vioxxadvisor.com/4189.html A federal judge overseeing a $4.85 bi